AccountSonarAll accounts

Company profile

Eli Lilly

Pharmaceuticals · Indianapolis, Indiana · lilly.com

Eli Lilly and Company, founded in 1876, is a global pharmaceutical leader headquartered in Indianapolis, Indiana. The company focuses on developing innovative medicines across various therapeutic areas, including diabetes, oncology, immunology, neuroscience.

Strategic priorities

Enhancing Access to Medicines

To improve global health outcomes by making treatments more accessible.

Lilly's commitment to increasing access to medicines is a core aspect of its mission.

About Us | Eli Lilly and Company

Advancing Scientific Innovation

To drive breakthroughs in medicine through cutting-edge research.

Lilly's dedication to scientific excellence is evident in its continuous pursuit of pharmaceutical innovation.

About Us | Eli Lilly and Company

Fostering Inclusive Culture

To create a diverse and respectful work environment.

Lilly emphasizes cultivating an inclusive culture as a fundamental value.

About Us | Eli Lilly and Company

Environmental Responsibility

To minimize environmental impact and promote sustainability.

Lilly's environmental goals reflect its commitment to reducing its ecological footprint.

About Us | Eli Lilly and Company

Ethical Operations

To maintain integrity and responsibility in all business practices.

Lilly's ethics and compliance initiatives ensure responsible corporate conduct.

About Us | Eli Lilly and Company

AI program

Lilly has launched TuneLab, an AI and machine learning platform providing biotech companies access to drug discovery models trained on over $1 billion in research data. This initiative aims to accelerate the development of breakthrough medicines by leveraging Lilly's extensive datasets.

Technology posture

Lilly is integrating advanced technologies to enhance drug discovery and operational efficiency.

Cloud
4/5
AI
5/5
Data
5/5

Lilly's AI initiatives, such as TuneLab, demonstrate a strong commitment to technological advancement in pharmaceutical research.

Technology vendor categories

Cloud
n/a
Data
n/a
AI
n/a
ERP
n/a
CRM
n/a
Security
n/a

Recent developments

Sources

Get the full sourced brief on Eli Lilly

This is a neutral public preview. Sign in to generate your own personalized brief, with stakeholder angles, talk tracks and where your solution fits, tailored to how you sell.

Generate a full brief

Your first brief is free, no card required.

Evidence confidence 90/100. Generated 2026-07-08 from public sources.